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Highlights 
 This comprehensive scoping review benchmarks the international evidence base for 
access to health and social care for MS patients  
 There are inequalities across the prevention, care and support pathway, particularly 
for men, older age groups, lower SES, and those with MH problems.  
 There are clear implications for clinicians, health organisations and national policies.  
 There are specific research gaps particularly for vulnerable groups and for patient 
information.  
 These findings will help to inform prioritisation of future research internationally for 
this population.  
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ABSTRACT (300 words unstructured) 
 
Variations in access to health care are known to contribute to differences in life 
expectancy, morbidity and health-related quality-of-life across population subgroups.  
We undertook a scoping review to identify what is known about in-country variations 
in access to services for adults with multiple sclerosis and to identify gaps in the 
literature to inform future research and national policies. We searched MEDLINE, 
CINAHL, EMBASE, PSYCHINFO, SocINDEX and Social Science Abstracts from 
inception to end of December 2016 for quantitative studies which had investigated 
differences in access to prevention services, healthcare services, treatments and 
social care between inequality groups, defined using the PROGRESS-PLUS 
framework. A total of 4959 unique abstracts yielded 36 papers which met our 
eligibility criteria.  Only 3 studies were cohort studies and only 4 were population-
based; most were from the United States (n=27). There were 6 studies on access to 
MS focused care and 6 on access to Disease Modifying drugs. There were 3 studies 
on access to prevention/lifestyle programmes and none on access to welfare 
services or information support. There were no papers examining inequalities in 
access for ‘vulnerable’ groups, such as, those with learning disability.  In the 
available studies, there was evidence of inequalities in access to services with a 
trend for worse access among men, older age groups, those from lower socio-
economic groups or the least educated, non-caucasians, those with mental health 
problems and those from rural areas. In the studies on access to disease modifying 
treatments, older age and lower socioeconomic status were consistently associated 
with a lower rate of uptake, while race and gender were not. Inequalities or 
disparities in access to all levels of services and treatments will need to be 
addressed through a strategic research agenda with an emphasis on population-
based studies and development and evaluation of interventions to reduce inequality.   
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INTRODUCTION 
 
Variations in access to health care are known to contribute to differences in life 
expectancy, morbidity and health-related quality-of-life across population subgroups 
[1-4].  When these variations are avoidable they contribute to inequalities or 
disparities in health experience [5] and have led to international and national 
strategies to reduce gaps in service provision, particularly, when there is evidence of 
lack of access to proven effective interventions or clinical variations in care [6-8].  
The Multiple Sclerosis Atlas has demonstrated gross international differences in 
mortality in multiple sclerosis and access to disease modifying treatments [9]. 
However, studies also suggest variations within countries, with some evidence that 
place of residence and sociodemographic characteristics (e.g., age, gender and 
ethnicity) have an influence on patient outcome [10-12].  There is also concern about 
variations in access to disease modifying treatments for some patient subgroups, 
which might be, in part, secondary to how health services are organised [13,14].  In 
chronic conditions like multiple sclerosis (MS), it is also important to consider 
inequalities in access to services and treatments which reduce morbidity across the 
care pathway, from secondary prevention to rehabilitation and social care [15]. The 
complex needs of many patients with MS require the input of many other services, 
such as physiotherapy, occupational therapy and mental health services, as these 
treatments/therapies have been shown to reduce morbidity in MS [16-18].  
Independence and participation may be maintained through social support, personal 
support and housing adaptations, and the employment consequences of an MS 
diagnosis through vocational rehabilitation [19].  More recently, there has been a 
greater focus on improving well-being through promoting healthy lifestyles among 
adults with multiple sclerosis, because of evidence that increased physical activity 
helps to maintain physical functioning and improve mental health in MS patients [20] 
and because smoking may raise the risk of disease progression [21].  Therefore, 
variations in access to lifestyle and prevention programmes is also important. 
We undertook a scoping review of the literature to identify what is known about in-
country variations in access to services for adults with MS and to identify gaps in the 
literature to inform future research and national policies.  A scoping review uses 
systematic methods to identify the literature but addresses a broader question than a 
systematic review. As  such, it is less concerned with the reporting quality of the 
papers or meta-analysis. In this scoping review, we identified and reviewed studies 
which used a quantitative methodology to investigate intra-national (in-country) 
variations in access across the care pathway and health systems of different 
inequality groups among populations of adult MS patients.  
 
METHODS 
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Although this study was not focused on the effectiveness of interventions to reduce 
inequity, we used the Joanna Briggs Institute guidance on scoping reviews [22] and 
the Cochrane and Campbell Equity methods group checklist [23] to guide the 
development of the study protocol, study implementation and presentation of 
findings. This study was funded by Salford Royal NHS Hospitals Foundation Trust. 
 
Definition of exposures (Inequality groups) 
We used the PROGRESS-PLUS framework for determining inequality groups in this 
review [24]. These were used to guide terms in the search strategy and to stratify 
studies in the analysis. In this framework the PROGRESS inequality groups (place of 
residence, race/ethnicity/culture/language, occupation/employment status, 
gender/sex, religion, education, socio-economic status, and social capital) were 
supplemented by ‘PLUS’ inequality groups related to personal characteristics 
pertinent to MS patients: age, disability (physical +/or cognitive), disease type, 
mental health conditions, and other ‘vulnerable groups’, e.g., learning difficulties, 
travelers, migrants.  The ‘PLUS’ groups were chosen based on the potential for 
barriers to access of services and/or treatments following discussion within the 
review team, which consisted of clinicians and public health professionals. When 
considering social capital, we took a broad and inclusive approach to its definition 
and included all aspects of social networks and social cohesion under this umbrella 
term [25]. We also included a broad range of indicators of socioeconomic status, e.g, 
deprivation indices, income.  
 
Definition of outcomes (programmes/services/treatments)  
À priori, we broadly categorised the programmes/services/treatments and, post-hoc, 
agreed subcategories for presentation when studies were found. The categories 
(and subcategories) included:  prevention programmes (subcategories: primary and 
secondary prevention), diagnostic investigations, medical care (subcategories: 
medication general, disease modifying treatments, general health care, neurology 
services, MS specific services, health provider systems e.g., health maintenance 
organisation), mental health services, rehabilitation services, social and welfare 
services (personal support, housing, assisted devices or assisted living) and 
information support. 
 
Eligibility criteria 
We included studies with a quantitative research design from any country and 
healthcare setting if they compared inequality MS groups as to uptake of, or access 
to programmes, services or treatments across the prevention/care/support pathway. 
Participants could have any type or stage of MS and be at any time following 
diagnosis. As the focus was on adult MS patients, we excluded any study in which 
more than 5% of the population was under 16 years of age. We also excluded 
studies comparing MS patients with the general population or with other patient 
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groups, studies investigating uptake of alternative or complementary therapies, those 
that focused on uptake of lifestyles rather than the services which promote lifestyle 
modification, those investigating DMT adherence rather than prescription and studies 
where the outcome was perceived or reported need, rather than comparative need.   
 
Search strategy 
We searched MEDLINE, CINAHL, EMBASE, PSYCHINFO, SocINDEX and Social 
Science Abstracts from inception to end of December 2016 using the key terms for 
multiple sclerosis as recommended by the Cochrane Multiple Sclerosis and Rare 
Diseases Review Group [26] and search terms for inequalities/disparities and the 
inequality groups, adapted as appropriate for the different databases. The search 
was limited to English Language articles. The full search strategy for MEDLINE 
(EBSCO) is included in supplementary materials (supplementary table 1). The titles 
and abstracts were screened by teams of two authors independently and any 
conflicts resolved by a third reviewer.  
 
Data retrieval, extraction and analysis 
Full text papers for all potentially eligible studies identified by the search, and when 
there was insufficient detail in the title/abstract to determine eligibility, were retrieved 
and screened for inclusion by two researchers, with a third reviewer resolving any 
conflicts.  Data was extracted for each of the identified studies using a specially 
designed proforma.  Data was extracted on the study design, country and setting, 
definition of MS, sample size, population characteristics, setting, data source, 
exposures (PROGRESS-PLUS categories), outcomes (uptake/access) and key 
findings for each exposure/outcome relationship reported. Data was extracted by 
one researcher and all data was checked by a second researcher, with conflicts 
being resolved by discussion. The dataset was synthesised narratively after 
discussion with the full review team. 
 
RESULTS 
A total of 4959 unique abstracts were identified from the databases following 
automatic removal of duplicates. This yielded 157 full text papers for eligibility 
screening and a further paper was identified from other sources [15].  A total of 36 
papers were deemed eligible for further analysis [15, 27-61]. Reasons for exclusion 
for the other 122 papers included: a lack of focus on inequality (n = 23); non-eligible 
study design (n= 26); non-eligible study population (n=18); exposures inconsistent 
with the PROGRESS-PLUS framework (n=27) or lack of data on access to a service 
or treatment (n=28).  Figure 1 shows the flow diagram of search results. 
Figure 1: Flow chart of search  
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
7 
 
 
 
The full characteristics of the 36 studies is shown in supplementary table 2. Only 3 
studies were cohort studies [28, 47, 55] and only 4 were population-based [46, 47, 
52, 58]. The data source for 12 of the 36 was in full, or in part, from the members of 
National Multiple Sclerosis Society [32, 33, 36, 37, 41, 42, 43, 48, 49, 53, 54, 56] and 
for 4 studies the North American Research Committee on Multiple Sclerosis 
(NARCOMS) register [30, 44, 45, 56]. There were also 4 studies which used the 
Minimum Data Set (MDS) for Medicare/Medicaid certified Nursing Homes (two of 
which used the same sample) [29, 31, 34, 35] and 3 which drew on a single survey 
(‘’Aging With MS: Unmet Needs in the Great Lakes Region" survey) [38, 39, 40]. The 
Records after duplicates 
removed  
n=4959 
Records identified through database searching 
(n=5113) 
Records identified from 
other sources (n= 1) 
Papers assessed for focus on 
health inequality and access 
to services 
n=158 
Papers excluded n=122 
-no inequality focus: 23 
-study design: 26 
-not population of interest: 18 
-not exposure of interest: 27 
-not outcome of interest: 28 
Studies included for data 
extraction  
n=36 
Records excluded on title and 
abstracts (n= 4802) 
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studies were published between 2000 and 2016 with 10 studies published since 
2010 [30, 38, 39, 46, 47, 51, 53, 55, 56, 61]. Most of the studies were undertaken in 
the US (n=27) and all studies were undertaken in North America or Western Europe.   
Figure 2 and table 1 show the numbers of studies focusing on the different access 
outcome categories and subcategories. There were 10 unique studies on access to 
medical services, of which, six studies were on access to MS focused care. Eight 
unique studies focused on access to medications, of which, 6 were on access to 
Disease Modifying drugs. A similar number of papers were on access to mental 
health services (n=7), rehabilitation (n=8), and social support/care (n=7). There were 
a few studies on diagnostic services (n=2), access to prevention/lifestyle 
programmes (n=3) and on housing adaptions or aids (n=4), but no studies on access 
to welfare services or information support.  All three studies about inequalities in 
access to health provider systems were from the United States.  
Figure 2: Number of papers by access subcategory 
 
 
 
Table 1 summary of findings here (see separate file) 
 
The effect of gender was examined across all access subcategories for which there 
were studies, and disability and socioeconomic status across all but one. Gender 
(n=25), age (n=21) and disability (n=18) were most frequently included as exposure 
factors.  In contrast, mental health status (n=9), occupation, i.e., employment status, 
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(n=9), and disease type (n=7) were less frequently examined. Given the setting of 
most of the papers, the 15 studies about race mainly focused on differences 
between Caucasian, African American and Hispanic populations.  Those on place 
(n= 13) compared urban and rural populations and all the papers categorised under 
social capital (n= 14) were on marital status or living arrangements. There were no 
papers examining ‘vulnerable’ groups or religion as factors affecting access to 
services/treatments.   
The findings for each access category is shown in table 1. There was evidence of 
inequalities in access to services, but the relationship was not consistent across 
access subcategories. Broadly, there was a trend for worse access among men, 
older age groups, those from lower socio-economic groups or the least educated, 
non-caucasians, those with mental health problems and those from rural areas. But 
these findings were not universal, for example, women were less likely than men to 
see an urologist or have a powered wheelchair, and younger patients were less likely 
to be in receipt of personal assistance.  In the studies on access to disease 
modifying treatments, older age and lower socioeconomic status were consistently 
associated with a lower rate of uptake, while race and gender were not.  The 
relationship between severity of disability and levels of access across the care 
pathway was complex; with evidence of worse access to primary prevention and 
neurology services, no evidence of access issues to MS specific care and better 
access to rehabilitation, social care and assisted living. 
 
DISCUSSION 
In the limited number of studies identified, the findings of this scoping review support 
the existence of inequality, or disparity, in access to services among MS 
subpopulations within countries. The subpopulations experiencing inequality are 
similar to those experiencing access or uptake issues in other conditions.  For 
example, in cancer screening men, minority ethnic groups and those from more 
deprived areas have lower rates of bowel screening [62]; older adults are less likely 
to receive proven effective treatments [63]; and rurality has been associated with 
lower access to specialist services [64]. However, this review also suggests that 
interpreting variations in access rates as an inequality or disparity is complex.  There 
was some evidence that inequalities may be context specific. For example, women 
rather than men were less likely to be referred to a urologist. Urinary symptoms are 
very common in multiple sclerosis, but one study suggested that only two thirds of 
patients are asked about these symptoms by their clinician [65]. Gender disparity in 
referral to urologists has also been observed in general populations with haematuria 
and voiding difficulties, with women less likely to be referred and more likely to be 
treated for urinary tract infections [66,67].  Depending on the population subgroup, a 
higher or a lower uptake rate might be interpreted as an inequality for the same 
service.  For example, in the study by Marrie [46], access to ICU was lower among 
those living in rural areas, which might suggest that because of the distance from 
specialist services those in rural areas could not obtain necessary management.  
However, access to intensive care units (ICU) was higher among men and older 
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patients. This could be interpreted as women and younger patients being less likely 
to benefit from necessary care; but equally could be interpreted that men and older 
patients are less likely to receive appropriate care to prevent overwhelming 
infections. Similarly, a lower rate of access to lifestyle interventions among those 
who are more disabled may be an inequality if they can benefit from these services; 
whereas a lower rate of access to home adaptations among those who are less 
disabled may not be an inequality, if they do not need such aids. These examples 
highlight the need for research to understand the reasons for differences between 
population subgroups: whilst some of these are likely to be similar to those 
experienced by adults with other co-morbidities [68], some are likely to be disease 
specific. Such research will also facilitate the development of strategies to reduce 
important variations.  
Further difficulties in interpretation were introduced by the study designs.  Few 
studies used a cohort design and therefore in most studies both exposure and 
outcome were measured at the same time.  While this may not affect some 
exposures (such as gender), the interpretation of the direction of effect can be more 
problematic for exposures such as mental health or disability.  So for example, in the 
study by Buchanan et al, nursing residents who were depressed were less likely to 
have occupational therapy (OT) [29].  As this was a cross-sectional study, it was 
unclear whether they had less OT because they were depressed, or not having OT 
made them depressed.  Furthermore, there were other concerns about the quality of 
these studies: not all studies undertook a multivariate analysis to assess whether the 
exposures were independent risk factors.  Few studies were population-based and 
many relied on members of MS societies: these groups might be less likely to 
include those from lower socio-economic groups, the less educated and minority 
groups [42, 43]. Finally, the generalisability of the findings may be limited because 
the majority were undertaken in US and all within western developed countries. Even 
then, the organisation and funding of health and social care systems in the US and 
the geography and racial breakdown are substantially different to that of, for 
example, the United Kingdom, where only 3 studies have been undertaken [15, 51, 
52]. 
There were a relatively high number of studies investigating access to disease 
modifying treatments. This is perhaps unsurprising, given the controversies around 
funding of these effective but expensive drugs; particularly when they first came to 
market [51]. More recent studies suggest that in addition to concerns about 
socioeconomic disadvantage having an impact on access to first line DMTs, there 
still remain concern about access of patients from lower socioeconomic groups to 
second line treatments [69]. There were very few studies about prevention 
programmes, which might reflect the relative recency of the interest in lifestyle 
interventions to promote well-being in MS populations. Nevertheless, promotion of 
physical activity, safe alcohol consumption and smoking cessation are incorporated 
into some national guidelines for MS care [70], and further work on access to these 
interventions overall and across inequality groups is warranted.  It is perhaps more 
surprising that there were no studies on access to vocational rehabilitation services, 
and few on the impact of unemployment on access to services, given the 
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considerable research on the difficulties encountered by adults with MS within the 
workplace and the detrimental impact of unemployment on their well-being [71, 72].  
We also found no studies about access to informational support. There is increasing 
interest in developing self-management programmes including digital technology for 
patients.  While such programmes are important to promote well-being and patient 
engagement [13], there is the potential for introducing further health inequalities, as 
access to and use of the internet or mobile devices differs across socioeconomic and 
racial groups [73].                 
As well as the difficulties in interpretation, there were other limitations to our scoping 
review.  Because of resource limitations, only studies in the English language were 
included. This may in part account for the observation that there were relatively few 
countries included among the eligible studies.  We specifically excluded studies 
which focused only on perceived or expressed needs, as these are subjective. 
Studies reporting objectively measured needs were included, but perceived or 
expressed needs may under represent genuine inequalities as they may represent 
wants, although studies have shown that these can vary across inequality group [74]. 
We did not include qualitative studies as the objective was to compare across 
inequality groups, but these types of studies would give greater depth of 
understanding of why inequalities exist. Finally, the concluding step in Arksey and 
O’Malley’s original structure for scoping reviews includes a discussion with 
stakeholders of the findings [75].  This has not been formally undertaken with 
external stakeholders, but was addressed internally by the review team which 
included both researchers and clinicians. A recent scoping review on the conduct 
and reporting of scoping reviews suggests relatively few published scoping reviews 
undertake this step [76].  
 
CONCLUSION 
This scoping review was essential to benchmark the current evidence base and to 
demonstrate the paucity of published studies to date for this population. It has 
identified that inequalities exist throughout the prevention, care and support pathway 
for adults with MS, but the interpretation of these findings are limited by the lack of 
consistency between studies and across different types of care or support.  In part, 
this may be because inequality is likely to be context specific and, in part, because of 
the limitations of the study design. There were also some specific research gaps 
identified, particularly in relation to prevention, vocational support and patient 
information and within inequality groups, learning disabilities and other ‘vulnerable’ 
groups. Inequalities or disparities in access to all levels of services and treatments 
will need to be addressed through a strategic research agenda. Further research to 
explore these areas requires large-scale population-based databases to ensure that 
participants are representative. Longitudinal studies also need to be responsive to 
changes in evidence about the management and treatment of MS.  Further research 
is needed into understanding the reasons for differences in access to develop 
strategies to address any inequality. The findings of this scoping review will help to 
inform the prioritisation of future research for this population internationally.  
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Table 1: Number of studies investigating each access subcategory and summary of findings (number 
in brackets are the references of the papers; SE = socioeconomic)   
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  Summary of findings 
Lifestyle N=1 [53][53]     [53] [53]  [53]  [53]  [53]    [53]      
  
[53] 
 Males, those from less 
educated backgrounds 
and the more disabled 
were significantly less 
likely to access lifestyle 
and wellness services.[53]  
Secondary 
Prevention 
N=2 
[33] 
  
  
  
  
  
[57] 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
There was a trend 
towards fewer men 
taking calcium 
supplements and having 
a DEXA scan,[57]  and MS 
patients in urban areas 
being less able to access 
mammography, because 
of lack of adaptation for 
physical problems.[33] 
 
Diagnostic 
investigation 
N=2 
[33] [44]  [44]  [44]   [44]    In a multivariate 
analysis, women and 
non-white MS patients 
were less likely to see a 
urologist and have 
urological investigation. 
[44]    
In Buchanan et al (2005), 
similar proportions of 
patients with MS in 
urban and rural areas 
could not have a 
diagnostic procedure 
because the equipment 
could not accommodate 
their impairments.  
General 
hospital care 
N=6 
[32], 
[33],  
[35],  
[46] 
 [56] [46], 
[56] 
 [46]  [46] [56] 
 
 [60] Veterans with major 
depression had more 
frequent primary care 
visits.[60] The unemployed 
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had more difficulty 
attending medical 
appointments.[56] One 
study suggested no 
differences in overall 
access to general care 
between rural and urban 
areas;[32] access issues 
may differ though with 
those in rural areas citing 
proximity[33], and in 
urban areas, physical 
challenges.[32] Nursing 
home residents in rural 
areas were less likely to 
receive domiciliary 
visits[35].  Non-urban 
residents were also less 
likely to access ICU, but 
men and older patients 
were more likely.[46]  
Neurologist 
care 
N=2 
[49] [30],  
[49],  
 [49]  [49]  [49] [49]   Men, older patients, the 
more severely disabled, 
rural dwelling patients, 
and those with lower 
income were less likely 
to see a neurologist.[49] 
There was conflicting 
evidence about race, one 
study suggested no racial 
differences,[30] while the 
other suggested African 
Americans were less 
likely to see a 
neurologist.[49] 
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MS specialty 
services 
N=5 
[32], 
[33], 
[55] 
[30]  [47], 
[55] 
 [47]  [47], 
[55] 
[55] [55] [47] Two studies suggest 
place may impact access 
to specialty MS services; 
Ribes Garcia et al (2016) 
observed regional 
differences,[55] and 
Buchanan et al (2005) 
showed significantly 
worse access for patients 
from rural areas: issues 
for those in rural areas  
were cost, greater 
reliance on others to 
access and a lack of 
nearby facilities[33]/[32]. 
Those with mental health 
problems[47] and African 
Americans[30] were less 
likely to access specialist 
MS services. The 
evidence for age was 
conflicting with one of 
the two studies 
suggesting worse access 
among older MS 
patients.[47]  
Disease 
modifying 
treatments 
N=6 
[55] [27],  
[30],  
[41] 
[41] [27], 
[41], 
[51], 
[55], 
[61] 
[41] [27], 
[41], 
[51]  
[41]  [27], 
[41], 
[51], 
[55]  
[51], 
[55]  
[41], 
[55]  
 Only one of three studies 
suggested racial 
differences in 
prescription of newer 
drugs.[30]  Four studies 
explored the relationship 
between gender and 
DMT use; but of the 
three which took into 
account other variables, 
two did not demonstrate 
a relationship between 
gender and uptake.[51], [41] 
Older age was associated 
with lower prescription 
rates in all studies 
investigating this and 
most studies suggested 
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that lower 
socioeconomic status or 
unemployment was 
associated with lower 
levels of prescription. [51]  
[27] [41] In a multivariate 
analysis, region, male 
gender, older age and 
disease type were 
associated with a lower 
rate of change from first 
to second line DMD.[55]   
Other 
medication 
N=5  
 [31],  
[34], 
[44] 
 
 [44], 
[61] 
 [44]   [44]  [29] Men and those without 
private health insurance 
were less likely to receive 
prescriptions for bladder 
symptoms, [44]. Men were 
less likely to receive 
relapse therapy 
medication, and 
symptomatic treatments 
including 
antidepressants, NSAIDS 
and hypnotics; women 
were less likely to receive 
anti-fatigue and muscle 
relaxant medications.[61] 
African American MS 
patients were 
consistently less likely to 
be prescribed anti-
anxiety and anti-
depressant medication 
prescriptions in the two 
studies that investigated 
these factors. [31], [34]  
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Mental 
health 
services 
N=7 
[35], 
[37], 
[45] 
[30], 
[31],  
[45]  
 
 [28], 
[40], 
[45]  
[40], 
[45] 
[45] [28], 
[40], 
[45] 
[28], 
[40], 
[45] 
[40]  [28] Two of three studies 
suggest that rurality [37], 
[35] and lower education 
status[45],[40] was 
associated with lower 
access to mental health 
services. Only one of 
three studies 
investigating these 
factors suggested racial, 
[30] age[28] or social 
support differences.[28]   
Rehabilitation 
services 
N=8 
[35], 
[38], 
[50]  
 
[30],  
[31], 
[34], 
[50] 
 
 [38], 
[50] 
[38],  
[50] 
[38], 
[50] 
 [38], 
[50] 
[15], 
[38], 
[50] 
 
 [29], 
[50] 
 
Two studies suggested 
that those living in rural 
areas had less access to 
rehabilitation services. 
[38],[35] One study 
suggested that Latinos 
were significantly less 
likely to receive 
rehabilitation compared 
with Caucasians and 
African Americans, [30] 
but other studies 
showed no racial 
differences.  Studies 
investigating disability, 
found that the most 
disabled were 
significantly more likely 
to access therapy 
services.[50],[38],[15]  
Residents in nursing 
homes who were 
depressed were 
significantly less like to 
have OT, physical 
therapy and respiratory 
therapy but more likely 
to have nutritional 
therapies.[29]  
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Health 
service 
organization 
 
N=3 
 
[36], 
[48] 
[48], 
[59] 
  
[48], 
[59]  
  
[48], 
[59] 
[48], 
[59] 
[48] [48], 
[59]] 
[48], 
[59] 
[48], 
[59] 
[48] [48] Three studies examined 
inequalities within the US 
health system. The 
unemployed and 
disabled were 
significantly less likely to 
access independent 
practice association;[59] 
whereas African 
Americans and least 
educated were more 
likely to be enrolled in an 
HMO [59] but those in 
rural areas less likely[36]; 
older patients and 
separated and divorced 
more likely to access fee 
for service. [59]   Minden 
et al (2007) found that 
MS patients were less 
likely to be insured if less 
educated, not in full-time 
employment, had low 
income, rural residence 
or progressive disease or 
were in receipt of mental 
health care.[48] 
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Community 
care/social 
care  
N=7 
[35],  
[39]  
  
[54]  
 
 
[52],  
[54] 
 
[39], 
[52], 
[54],  
[58]  
 
[39],  
[54] 
] 
[48],  
[54] 
 
[39],  
[52], 
[54] 
 
[39],  
[52], 
[54], 
[58] 
  
[15],  
[39], 
[52], 
[54], 
[58] 
] 
[52],  
[54] 
 
[29],  
[54] 
  
One study investigating 
access to respite care in 
nursing homes showed 
no difference between 
MS patients with 
depression and those 
without.[29]  Three studies 
examined access to 
formal personal 
assistance, all showed 
those with worse 
disability had better 
access[54],[58],[15]; 
significantly lower 
uptake was seen in those 
with lower educational 
status, without spousal 
support and on military 
insurance in a 
multivariate analysis[54]; 
while Sundstrom et al 
[58] reported that 
receipt was lower in 
younger patients.[58]  
Nursing home residents 
from rural areas were 
less likely to receive 
training in community 
skills[35] but there was no 
difference between 
those with and without 
depression.[29] One study 
showed lower access to 
community nurses, social 
workers and day centre 
care among the less 
disabled. 
Adaptions/ 
aids/ 
supported 
living N=4 
 [42],  
[43], 
[54] 
42] 
 
[42],  
[43], 
[54]  
 
 
[42],  
[43], 
[54]  
 
 
[42],  
[43], 
[54]  
 
 
[42],  
[54]  
 
 
[15], 
[42],  
[43], 
[54]  
 
 
[15], 
[42],  
[43], 
[54]  
 
[15],  
[43], 
[54]  
 
 
[42],  
[43], 
[54]  
 
 
 
 Use of memory aids was 
lower in older patients 
and those less 
educated.[43] The use of 
assistive technology was 
lower in those with 
spousal or partner 
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KEY: DEXA = Dual-energy X-ray absorptiometry; DMD = Disease Modifying Drugs; DMT = Disease 
Modifying Treatment; HMO = House in Multiple Occupation; ICU = Intensive Care Unit; MS = 
Multiple Sclerosis; NSAID = Non-steroidal anti-inflammatory drug; OT = Occupational Therapy. 
 
 
support in two of the 
three studies examining 
this[42], [54]. The study by 
Iezzoni et al (2008) 
suggested women were 
less likely to have 
powered wheelchairs.[42]  
There was lower uptake 
of assistive technology 
among those with worse 
mental health in the 
study by Putnam and 
Tang [54]. 
